NIDA Hosts Meeting to Review Drug Research Funding
Published Date: 8/15/2025
Notice
Summary
The National Institute on Drug Abuse is holding a hybrid meeting on September 9, 2025, to review grant applications and discuss important drug research topics. Anyone interested can join in person or online, but space is limited, and some parts of the meeting will be private to protect sensitive info. This meeting affects researchers seeking funding and helps guide future drug abuse studies.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 0 costs, 2 mixed.
NIDA Will Review Grant Applications
On September 9, 2025, the National Advisory Council on Drug Abuse will meet and will review and evaluate grant applications during a closed session from 10:30 a.m. to 11:45 a.m. The closed session is to protect confidential trade secrets, patentable material, and personal information of applicants.
Public Can Attend Hybrid Meeting
The meeting on September 9, 2025 has an open hybrid session from 1:00 p.m. to 5:00 p.m. You can attend in person or virtually by registering at the link provided, but attendance is limited to space available.
Accessibility and Security Requirements
If you need special assistance such as sign language interpretation to attend the meeting, you must notify Dr. Gillian Acca by email at least five days before the meeting. In-person attendees will be subject to NIH campus security procedures, including showing one form of identification and vehicle inspection.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2025-15504 — Certain Hot-Rolled Steel Flat Products From Japan: Final Results of Antidumping Duty Administrative Review; 2022-2023
The U.S. checked prices on hot-rolled steel from Japan and found that Nippon Steel Corporation sold it in the U.S. for less than fair value from October 2022 to September 2023. Because of this, extra duties (taxes) will apply to their steel imports to keep things fair for American businesses. This means importers might pay more soon, so everyone should stay tuned for updates.
Next: 2025-15506 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings this fall to review important grant applications focused on fighting antibiotic-resistant bacteria, cancer research, and drug discovery. These meetings keep sensitive info private and help decide which projects get funding. Scientists and researchers applying for grants should note the dates in September and October 2025.